We haven't been able to take payment
You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Update payment details
Act now to keep your subscription
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Update payment details
Your subscription is due to terminate
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account, otherwise your subscription will terminate.
Update payment details

Accessibility Links

Skip to content
The Times & The Sunday Times
The Times & The Sunday Times
  • Subscribe
Subscribe

Taylor Wessing

The Times

Lawyers 1,100
Turnover £371.3 million
Offices 29

Taylor Wessing is focused on technology, life sciences and private wealth. This year it has worked with organisations such as Centessa Pharmaceuticals, Ventyx Biosciences and Apollo Therapeutics on multimillion-dollar fundraising projects.

It also advised the pioneer biotech company Nuclera on its acquisition of part of E Ink, which will make components for Nuclera’s planned “desktop protein and gene printer”, intended to be used in healthcare and agriculture.

The firm opened a new office in Dublin in September.

★ Commended for inheritance & succession; intellectual property; tax; technology, media & telecoms

Advertisement

taylorwessing.com

To browse the 200 Best Law Firms 2022, go to thetimes.co.uk/bestlawfirms